key: cord-0938492-otmrsn7x authors: Bogale, Kaleb T.; Urban, Valerie; Schaefer, Eric; Bangalore Krishna, Kanthi title: The Impact of COVID‐19 Pandemic on Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes: A Single‐Centre Study in Central Pennsylvania date: 2021-02-17 journal: Endocrinol Diabetes Metab DOI: 10.1002/edm2.235 sha: 574a3c9fb879323810940a5c99e1f49a6ce4113f doc_id: 938492 cord_uid: otmrsn7x OBJECTIVE: We conducted this study to investigate whether the COVID‐19 pandemic impacted the rate of DKA and previously identified risk factors in children presenting with T1D. METHODS: We performed an extension of a retrospective analysis of all paediatric patients (age ≤ 18) newly diagnosed with T1D within a tertiary care referral centre between 01/01/2017 and 09/14/2020. Demographics, insurance coverage and clinical documents 30 days before their T1D diagnosis were abstracted to assess for symptoms at diagnosis, laboratory values (blood glucose, HbA(1c), venous pH and bicarbonate) and any healthcare encounters within 30 days of their diagnosis of T1D. RESULTS: 412 patients with T1D [171 F:241 M; 370 pre‐COVID era:42 post‐COVID era] were included. The percentages of DKA diagnoses at admission were very similar between the pre‐COVID and post‐COVID groups (47% vs. 48%), as were the severity (13% vs. 14% mild DKA; 33% vs. 31% moderate or severe DKA). CONCLUSION: There were no fluctuations in the rate of DKA among paediatric patients newly diagnosed with T1D throughout the coronavirus pandemic in central Pennsylvania. COVID-19 pandemic, while others reported no change 4,5 . We conducted this study to investigate whether the COVID-19 pandemic impacted the rate of DKA and previously identified risk factors in children presenting with T1D in a single tertiary care referral centre in central Pennsylvania. We performed an extension of a retrospective analysis of all paediatric patients (age ≤ 18) newly diagnosed with T1D within a ter- Our study was the first assessment of the rate of DKA at diagnosis of T1D within central Pennsylvania throughout the COVID-19 pandemic. We found similar overall DKA rates and severity throughout the COVID-19 pandemic to an earlier assessment of newly diagnosed T1D in the paediatric population in the same region 3 . Alternatively, there are reports of increased frequency 5 pandemic would be of interest, particularly to elucidate any regional differences and their potential causes. The findings of this investigation offer clinicians a simple and cost-effective means to rapidly riskstratify children for development of DKA throughout the COVID-19 pandemic. F I G U R E 1 Time series of the proportion of patients with a DKA diagnosis at the time of admission by approximately 6-month periods from 1 January 2017 to 14 September 2020. The vertical lines for each period represent the 95% confidence interval for the proportion The authors would like to thank the dedicated staff of the Penn State Hershey Pediatric Diabetes Clinic. No authors report a conflict of interest. wrote and edited the final manuscript. The study has institutional IRB approval. The data that support the findings of this study are available from the corresponding author upon reasonable request. Note: A total of 27 patients (6.6%) had a missing value for at least one of the variables included in the model. These patients were excluded when fitting the model. Odds ratios (ORs) and corresponding 95% CIs for parameters in the model are shown. Bold font signifies p-value ≤ 0.05. Abbreviations: ED, emergency department; PCP, primary care provider. Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control Medical costs among youth younger than 20 years of age with and without diabetic ketoacidosis at the time of diabetes diagnosis Prevalence and factors associated with diabetic ketoacidosis at diagnosis of type 1 diabetes: A report from a tertiary medical center in Central Pennsylvania Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany